View Item 

Show simple item record

The Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issue
dc.contributor.authorJamerson, Kenneth A.en_US
dc.date.accessioned2010-06-01T22:27:42Z
dc.date.available2010-06-01T22:27:42Z
dc.date.issued2004-04en_US
dc.identifier.citationJamerson, Kenneth A . (2004). "The Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issue." The Journal of Clinical Hypertension 6(s4): 4-10. <http://hdl.handle.net/2027.42/75451>en_US
dc.identifier.issn1524-6175en_US
dc.identifier.issn1751-7176en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75451
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15073461&dopt=citationen_US
dc.format.extent681427 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherLe Jacq Communications, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights2004 Le Jacq Communications, Inc.en_US
dc.titleThe Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issueen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid15073461en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75451/1/j.1524-6175.2004.03563.x.pdf
dc.identifier.doi10.1111/j.1524-6175.2004.03563.xen_US
dc.identifier.sourceThe Journal of Clinical Hypertensionen_US
dc.identifier.citedreferenceMcCord C, Freeman HP. Excess mortality in Harlem. N Engl J Med. 1990; 322: 173 – 177.en_US
dc.identifier.citedreferenceAnderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep. 2002; 50: 1 – 85.en_US
dc.identifier.citedreference3 Morbidity and Mortality: 2002 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 2002.en_US
dc.identifier.citedreferenceChobanian AV, Bakris GL, Black HR, et al. The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560 – 2572.en_US
dc.identifier.citedreferenceChrysant SG, Danisa K, Kem DC, et al. Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension. 1979; 1: 136 – 141.en_US
dc.identifier.citedreferenceSvetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999; 159: 285 – 293.en_US
dc.identifier.citedreferenceCooper R, Rotimi C. Hypertension in blacks. Am J Hypertens. 1997; 10: 804 – 812.en_US
dc.identifier.citedreferenceCooper RS, Rotimi CN, Kaufman JS, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care. 1997; 20: 343 – 348.en_US
dc.identifier.citedreferenceCooper R, Rotimi C, Ataman S, et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997; 87: 160 – 168.en_US
dc.identifier.citedreferenceCushman WC, Reda DJ, Perry HM, et al. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 2000; 160: 825 – 831.en_US
dc.identifier.citedreferenceRoccella EJ, Lenfant C. Regional and racial differences among stroke victims in the United States. Clin Cardiol. 1989; 12: IV18 – IV22.en_US
dc.identifier.citedreferenceLackland DT, Egan BM, Jones PJ. Impact of nativity and race on “Stroke Belt” mortality. Hypertension. 1999; 34: 57 – 62.en_US
dc.identifier.citedreferenceMaterson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993; 328: 914 – 921.en_US
dc.identifier.citedreferenceDahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002; 359: 995 – 1003.en_US
dc.identifier.citedreferenceJulius S. The LIFE study: special implications for African Americans. Presented at: 2002 International Society on Hypertension in Blacks Annual Meeting; June 8–12, 2002; Miami, FL.en_US
dc.identifier.citedreferenceFleming T, Borer J, Armstrong PW, et al. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Circulation. 2003; 107: e9002 – e9003.en_US
dc.identifier.citedreferenceWright JT, Bakris G, Greene T. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial. JAMA. 2002; 288: 2421 – 2431.en_US
dc.identifier.citedreference18 ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002; 288: 2998 – 3007.en_US
dc.identifier.citedreferenceDouglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003; 163: 525 – 541.en_US
dc.identifier.citedreference20 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265: 3255 – 3264.en_US
dc.identifier.citedreferenceCushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002; 4: 393 – 405.en_US
dc.identifier.citedreferenceSaunders E. Managing hypertension in African-American patients. J Clin Hypertens (Greenwich). 2004; 6 ( 4 suppl 1 ): 19 – 25.en_US
dc.identifier.citedreferenceAgodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001; 285: 2719 – 2728.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1524-6175.2004.03563.x.pdf
Size:
665.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.